For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

30th Jun 09

Pharmaxis Closes Share Purchase Plan

Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced it had raised A$7.2 million from its
Share Purchase Plan which closed on 24 June 2009. Shareholders of the company were
given the opportunity to purchase up to $5,000 worth of shares each at the $2.35 price
paid by institutional investors in the recent placement.

Read full media release - pdf
16th Jun 09

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

Pharmaceutical company Pharmaxis (ASX:PXS, Nasdaq:PXSL) is pleased to announce that
additional results of its recently completed international Phase III trial of Bronchitol in patients
with cystic fibrosis have been presented at the 2009 European Cystic Fibrosis Conference in
Brest, France.

Read full media release - pdf